In addition, use of an anti-TGF-β1 neutralizing antibody to block TGF-β/Smad3 signaling protects mice from obesity, diabetes, and hepatic steatosis (Tan et al., 2011; Yadav et al., 2011). The gene discussed is TGFB1; the disease is obesity due to melanocortin 4 receptor deficiency.